Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Apr;34(4):654–656. doi: 10.1128/aac.34.4.654

Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections.

J S Daly 1, M G Worthington 1, R J Andrews 1, R B Brown 1, R Schwartz 1, D J Sexton 1
PMCID: PMC171660  PMID: 2344171

Abstract

We compared treatment with one daily intravenous dose of cefonicid and multidose nafcillin in 65 patients with severe infections of the skin or skin structure. Clinical cure or improvement was achieved in 91% of the patients given cefonicid and in 87% of the patients given nafcillin (P = 0.97). The use of cefonicid may allow outpatient therapy of some severe infections.

Full text

PDF
654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blair A. D., Maxwell B. M., Forland S. C., Jacob L., Cutler R. E. Cefonicid kinetics in subjects with normal and impaired renal function. Clin Pharmacol Ther. 1984 Jun;35(6):798–803. doi: 10.1038/clpt.1984.115. [DOI] [PubMed] [Google Scholar]
  2. Bradsher R. W., Jr, Snow R. M. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen. Am J Med. 1984 Oct 19;77(4C):63–67. [PubMed] [Google Scholar]
  3. Gordin F. M., Wofsy C. B., Mills J. Once-daily ceftriaxone for skin and soft tissue infections. Antimicrob Agents Chemother. 1985 Apr;27(4):648–649. doi: 10.1128/aac.27.4.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Pankey G. A., Katner H. P., Valainis G. T., Clarkson M. J., Cortez L. M., Dalovisio J. R. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment. Am J Med. 1985 Nov 29;79(5B):106–115. doi: 10.1016/0002-9343(85)90141-x. [DOI] [PubMed] [Google Scholar]
  5. Slutkin G., Marzouk J., Dall L., Mills J. Comparison of cefonicid and cefazolin for treatment of soft-tissue infections. Rev Infect Dis. 1984 Nov-Dec;6 (Suppl 4):S853–S856. doi: 10.1093/clinids/6.supplement_4.s853. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES